-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Ultragenyx Pharmaceutical Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
- Ultragenyx Pharmaceutical Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -1.52 USD/shares, a 32.4% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -7.22 USD/shares, a 29.6% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. annual Earnings Per Share, Basic for 2023 was -8.25 USD/shares, a 18.5% increase from 2022.
- Ultragenyx Pharmaceutical Inc. annual Earnings Per Share, Basic for 2022 was -10.1 USD/shares, a 51% decline from 2021.
- Ultragenyx Pharmaceutical Inc. annual Earnings Per Share, Basic for 2021 was -6.7 USD/shares, a 118% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)